A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.
August 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.
December 2021 in “Journal of pharmaceutical research international” Trichoscopic features can help dermatologists distinguish between female pattern hair loss and chronic telogen effluvium.
January 2025 in “Thieme Medical and Scientific Publishers Private Limited eBooks” 15 citations
,
May 2022 in “Journal of Investigative Dermatology” Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.
5 citations
,
July 2019 in “Photodiagnosis and photodynamic therapy” Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.
3 citations
,
January 2017 in “Acta Dermato Venereologica” Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.
August 1994 in “Journal of Dermatological Science” 1 citations
,
January 1980 in “Acta Dermato Venereologica” Oral tetracycline reduces fat breakdown in hair lipids.
September 2023 in “Journal of the American Academy of Dermatology” Oral difelikefalin significantly reduces itch in notalgia paresthetica.
2 citations
,
February 2018 in “Journal of dermatology & cosmetology” Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.
January 2020 in “International Journal of Trichology” PRP injections are not effective for long-term treatment of temporal triangular alopecia.
14 citations
,
May 2016 in “Therapeutic advances in urology” Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.
1 citations
,
May 2017 in “Journal of the American Academy of Dermatology” Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.
27 citations
,
February 2017 in “Clinical, Cosmetic and Investigational Dermatology” New compounds were found to help increase hair growth and decrease hair loss.
2 citations
,
January 2011 Researchers developed a quick and accurate method to measure finasteride and tamsulosin in tablets.
May 2016 in “American Academy of Pediatrics eBooks” Telogen effluvium is a condition that causes temporary hair loss.
5 citations
,
May 2011 in “Movement Disorders” Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.
September 2025 in “Modern medical technology” FUE with DHI effectively restores natural hair growth in difficult scalp areas.
TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.
130 citations
,
February 2018 in “Journal of Investigative Dermatology” Tofacitinib may help treat severe hair loss, but more research is needed.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.
8 citations
,
April 2020 in “Facial Plastic Surgery Clinics of North America” Follicular Unit Transplantation is a reliable hair restoration method with a high success rate and minimal scarring.
20 citations
,
December 2016 in “Neurodegenerative disease management” Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.
August 2025 in “Journal of the American Academy of Dermatology” 36 citations
,
March 1989 in “British journal of dermatology/British journal of dermatology, Supplement” DPCP is more effective than tretinoin gel for treating severe alopecia.
April 2022 in “Jurnal Ilmiah Kesehatan Media Husada” Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.
March 2026 in “Skin Appendage Disorders” Telogen effluvium is linked to low ferritin and vitamin D levels.
July 2022 in “British Journal of Dermatology” Serum ferritin levels do not cause hair loss in women with telogen effluvium.